Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, you're talking BS. The company continues to make steady progress through multiple late stage clinical trials. If that continues, significant share price appreciation is simply a matter of time. I'm willing to wait, and am happy that management doesn't concern themselves with short term nonsense.
Oh look, a kitty!!!!!
That is simply ridiculous.
LONG TERM, Dude.
Short term or long term shareholder value? Leo is doing a wonderful job at focusing on LONG TERM shareholder value, which is by far the most important of the two.
Just like the calls for the company to "buy shares to support stock price". Really? People want the company to squander precious cash reserves in an attempt to manipulate short term stock price? To what end? In exactly what way would diverting money and attention to near term share price move forward the actual company goals of developing valuable, important, life changing drugs that can be sold eventually for billions of dollars?
It's almost like some people look for anything with which to bash the company, no matter how short sighted or unreasonable or transparent. It's almost like there are some people who don't really care about long term success... Can that be?
DOTB
I'd pay the $5 to make it stop...
Not a "POS". It's a clinical stage biotech in the middle of several mid to late stage successful trials, with three separate pipelines, where success with any one of their three drugs would rocket the share price of IPIX to the moon.
Hardly a poster child for a typical "pink sheet shell company". I mean seriously.
DOTB
Wow. BID is 2 Cents. TWO CENTS.
Hoping that reward includes free clothing and meals... and all the finest accommodations the Federal Prison at Leavenworth has to offer.....
My DIME prediction was early, but correct.
It was made last year with the stock trading above 30 cents.
This sham was held from collapse only by relentless illegal daily 100 share paint jobs at the ask for months and months that took advantage of the obscene spreads which often are 2:1 ask vs bid. Now, even that daily fraud can't keep this thing alive.
This time next year this stock will be:
1) Trading at a penny or below
2) Suspended due to SEC intervention
What's your pick?
DOTB
Last Chance to Bail Before Breaking a Dime!
High volume today, last rats leaving the ship at the dime level. Next stop lower... quickly, on the way to a penny.
This was always a total scam, hyped by criminals.
DOTB
This pig was pretty easy to manipulate for a very long time with the extremely low daily volume and HUGE, 30%+ bid/ask spreads. But now, even the 100 share EOD painters have given up! Apparently not even worth the $40 a day manipulation trade in order to keep the scam from revealing it's true value and burrowing into the ground.
This sham would have been trading at a dime MONTHS ago had it not been for the relentless daily EOD manipulations. And was it a coincidence that all the loud mouth "gems" pumpers disappeared at about the same time? Some of those folks that posted dozens and dozens of times a day on various boards have now all but disappeared from iHub! Shame.
DOTB
Someone's underwater on thousands of paint job shares!
Every last one of those thousands of fraudulent EOD paint job shares is now underwater. Most by at least 50%.
That makes me smile!
Maybe this "Friedman" of which you speak?
THERE IT IS! THE 100 SHARE EOD PAINTER!!!
Not two minutes after my post, we got it! Two separate 100 share painters at the 70 cent ask.
Here are all the trades today. 5,800 shares:
SNST Time & sales -- All Trades on 3/27
11:42:16 0.48 5000 -- legitimate trade
12:01:09 0.699 100 -- paint job in response
15:43:00 0.432 550 -- legitimate trade
15:50:24 0.70 100 -- paint job in response
15:50:24 0.6999 100
100 SHARE PAINT JOB AGAIN TODAY???
Ten minutes before the close. Let's see if we get the typical scamming 100 share paint job to hoist this pig back to 70 cents right before the close.
Currently down 31% on the day on 5.60k shares. Low for the day is .43 cents, which is nearly the low for all of 2017.
What a pig.
100 SHARE EOD PAINT JOB EVERY DAY!!!
The fact that there's a 100 share buy-at-the-ask paint job within the final few minutes of every trading day tells you all you need to know about this turd.
Here was today's Time @ Sales for SNST
time size price
11:24:38 890 0.60 -- real trade
11.29:53 1555 0.55 -- real trade
11:46:57 100 0.799 -- *** PAINT JOB ***
13:35:51 10000 0.65 -- real trade
15:59:56 100 0.785 -- ** PAINT JOB **
Wait a few weeks for the .10's, and you'll get three times the bang for your buck.
Well, it's true your risk is currently defined at only 55 cents per share. I guess that's the silver lining in the precipitous 85%+ share price collapse over the past months...
So there are three kinds of facts, then? The ones to like, the ones to ignore, and the ones that aren't really facts at all?
Dangerous.
You failed to mention their failure to file financials. That doesn't bother you either?
You're putting your faith in a Pink Sheet company that has failed to file their financials?
Pink Sheet.
Failure to file financials.
Really???
So ignore the facts, ignore the warnings, ignore the failure to file financials, ignore the huge discrepancy in market cap, and simply trust the judgements of a single trader.
Nice to know that where this tiny, thinly traded, non-reporting pink sheet company is involved, the actual facts just don't matter.
You offer no substance whatsoever to support your wild claims regarding this company. Nothing of substance.
Nothing to refute the fact that this pink sheet company has a STOP SIGN warning for failure to file financials, and that this warning includes a caution to investors:
http://www.otcmarkets.com/stock/SNST/quote
Nothing to refute the HUGE discrepancy between the company's claim of being worth $500M, and the market's valuation of the company at a 160th of that amount at $3M. Not half, not a forth, not a tenth... rather the market values this company at 1/160th of that suggested by its officers:
http://www.sunsetcapitalassets.com/about/
http://finance.yahoo.com/q/ks?s=SNST+Key+Statistics
Nothing to refute the fact that this stock is un-tradable with extremely low volume (and some days NO volume) and spreads of 50% to 100% a common occurrence. Impossible to get in, impossible to get out:
http://finance.yahoo.com/q/ks?s=SNST+Key+Statistics
Nothing to refute these facts. Nothing of substance. Nothing real.
Ignoring plain facts re:SNST is IRRESPONSIBLE, LAUGHABLE BS
Sorry, if it were real, it would be reflected in the share price and market cap, regardless of the liquidity of the asset. Something is wrong when the company says it's worth $500m, yet the market values it at $3m. The market obviously believes your point of view to be wrong, and believes the company to be nearly worthless.
And missing the reporting deadline for financials reporting is simply the nail in the coffin. They've failed to meet even PINK SHEET standards.
Good luck.
How do you personally reconcile the 150:1 difference in the company's statements as to value relative to the market's? Is the market "wrong", or do you simply not think about this glaring discrepancy? Do you personally believe the "gem" story and think the market simply doesn't get it? The value is in the "gems" and the market doesn't understand?
How do you personally ignore the failure of this company to meet it's financial filing deadlines? Why should the company get a pass for this? Why isn't this a huge red flag for you?
It's not a question of me being "right", it's a question of how owners and proponents of this company justify their opinions in the face of what seems to be objective facts in total opposition to those opinions.
How? Why? What's your thought process? Past wishful thinking, on what do you base your opinion of significantly higher share prices in the near term?
Company claims they're "well capitalized with assets valued in excess of $500 million" [website], yet market is valuing company at around $3m. The market is wrong by a factor of 166:1? Really? The company is right in their statements of value and the market is wildly, hugely, catastrophically wrong? Really??? Doesn't this go to credibility?
http://www.sunsetcapitalassets.com/about/
http://finance.yahoo.com/q/ks?s=SNST+Key+Statistics
Generally, many if not most Pink Sheet companies are scams and/or fail and disappear. SNST is a Pink Sheet company with an OTC STOP SIGN warning of missed financial filings and a warning to shareholders! Everything is fine and the OTC is wrong? Really???
http://www.otcmarkets.com/stock/SNST/quote
In what universe is this a safe investment? On what possible rational basis is it reasonable to forecast that this stock "returning to new highs"?????
Daily volume is pathetic at under 7,000 shares a day. Many days it doesn't trade at all. The bid/ask spread on many days is 50% or more. It's un-buyable, un-sellable -- simply un-tradable. What prevents this thing from finally collapsing to ZERO???
Same woman -- Nanopatent is correct, as usual. He's definitely identified the correct woman with his Facebook link.
Here's her page on the company website where she's listed as "Interim CFO". The picture is definitely of the same woman shown on the Facebook page:
http://www.sunsetcapitalassets.com/lisa-betros/
And again, Nano's Facebook link. Click on the inset picture at the lower left and browse here photo gallery:
https://m.facebook.com/lisa.betros?ref=content_filter
Apparently her background is in the Title industry. From the company website:
Ms. Betros, a native of Jacksonville, acts as (interim) Chief Financial Officer for Sunset Capital Assets, in addition to being Founder and CEO of Sunset Capital Title Services which is a full service Title Insurance Agency providing Title, Escrow and Closing Services. Sunset Capital Title is currently ranked #4 in the US Southeast region with orders increasing 400%+ year over year.
Previously, Betros owned and operated Allstate Title Group, LLC, for 15 years. The company enjoyed tremendous success and as the owner she was responsible for the balance sheet performance and the direction of the company. Allstate Title Group, LLC was an agent of Stewart Title Insurance and Land America, Allstate Title Group was recognized in the top 10% for the State of Florida, and a leader in closings for the US Southeast region.
Does she have the "jems" with her????? That would solve TWO mysteries!!!
100 share paint jobs won't save this pig.
OTC SNST WARNING! STOP SIGN -- DARK OR DEFUNCT!!!
Wow.
http://www.otcmarkets.com/stock/SNST/quote
No Information Warning
This company may not be making material information publicly available.
If you are an affiliate, employee, insider, or any person in possession of nonpublic material information about this company, please be advised that buying or selling this security may constitute trading "on the basis of" material nonpublic information prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators of these laws are subject to civil and criminal penalties.
Why does OTC Markets display this warning?
Companies that are identified on otcmarkets.com as having “No Information” may be placing their shareholders at risk of violating 10b5-1 insider trading rules. OTC Markets recommends that investors wishing to place a trade in such securities contact the company to verify it is making adequate current information publicly available.
UTTER COLLAPSE ON 25 TIMES AVG DAILY VOLUME!!!
Somewhere in Money Heaven an angel just earned his wings...
DON'T SAY YOU WEREN'T WARNED!!!
I'm never wrong predicting the demise of a smoke & mirrors "we have gems under the mattress" worthless crappy-ass financial scam.
Lost half of its value one day. What a surprise.
CONTEST: Guess Date SNST First Prints 50 Cents!!!
My guess is before Friday April 1st.
SUNSET SHARES WORTHLESS! TOTAL LOSS IMMINENT!
Extremely thin liquidity makes exit of any position over a few hundred shares impossible. Anyone owning this stock is trapped, and has no options left -- value will go to zero and complete position will become worthless.
It's over, save for the painful upcoming slow motion demise...
WOW!!! Under $1!!! CATASTROPHE!!!!!
WOW! Can it even hold $1??? Doubtful.
I was right! Couldn't hold $2!
What a TRAIN WRECK this turned out to be! It's a NO liquidity DEATH TRAP. Even if the balance sheet made sense (and of course we don't know if it does, because they don't publish audited financials), it's simply not possible to safely own significant quantities of any $2 stock that trades under 2,000 shares a day! Stocks this thin are impossible to accumulate without spiking share price, and worse, impossible to get OUT of without cratering it!
Honestly... owning more than a few thousand shares of this company is insane.
Friday's desperate EOD paint job not holding! Simply can't hold $2. $1.50 next stop ahead of the total collapse.
Tanking today. $2 is now just a memory...
NanoViricides Accelerates its Herpes Drug Development Program
http://finance.yahoo.com/news/nanoviricides-accelerates-herpes-drug-development-110000594.html
SHELTON, Conn., Aug. 17, 2015 /PRNewswire/ -- NanoViricides, Inc., (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide™ drug development program.
The Company will continue to develop its anti-herpesvirus franchise in parallel with the development of FluCide™, its anti-influenza drug candidate. The Company believes that drug development of the external treatments for the different herpes virus infections, such as topical skin creams or lotions for the treatment of herpes lesions, or shingles rash, as well as eye drops or gels for the treatment of herpes keratitis, are likely to require significantly less development work compared to the development of an injectable drug.
Biologics Consulting Group, Inc., a leading FDA regulatory consultant, is advising the Company on drug approval pathways and regulatory strategy.
Both the total amount of drug needed and the total amount of time needed for the pre-IND studies for any of the topical anti-herpes drug indications is expected to be much less than the corresponding projections for our injectable FluCide™ drug candidate for hospitalized patients with severe influenza.
The Company will continue the drug candidate and formulation optimization studies towards identification of the developmental drug candidates for IND applications. These studies will be performed to develop eye drops and gels for the treatment of HSV-1 herpes keratitis, as well as for skin cream and lotion formulations for the topical treatment of HSV-1 cold sores, HHV-3 shingles as well as HSV-2 genital lesions. The Company will then determine which indication it will follow first towards an IND. Unlike influenza, the herpesvirus efficacy studies are expected to need to be done with a very few HSV viral strains.
The Company has already successfully scaled up its drug production processes to 200g+ scale. The Company anticipates that this production scale may be sufficient for the tox package and other pre-IND studies for any one of the anti-herpes topical indications, whether for dermal application or for ocular therapy.
In addition, the Company is also continuing to scale up the production level of its different drug candidates to 1kg/batch, in order to enable production of the large amount of injectable FluCide needed for the Tox Package studies. The total amount needed for FluCide Tox Package studies was estimated at about 2~2.5kg, because of the extremely strong safety observed in preliminary safety toxicology studies in two different animal species.
The Company believes that it has sufficient financing available for IND filings and initial clinical trials of its drug candidates for at least two indications. The Company anticipates multiple indications to result from the HerpeCide and FluCide programs.
The Company recently disclosed that its anti-herpes drug candidates have demonstrated excellent efficacy in repeated experiments in a dermal infection model of zosteriform herpes in mice in two different laboratories.
The market size for herpes simplex virus treatments is in excess of $2 billion annually. The Company believes that a drug that is superior to existing therapies could result in significantly expanded market size.
Existing therapies against HSV include acyclovir, famciclovir and chemically related drugs These drugs must be taken orally or by injection and are not very effective as topical agents. Other drugs are largely ineffective. Currently, there is no cure for any of the herpesvirus infections.